Synutra is currently in ferrous bisglycinate kidsthferrous fumarate 210mg mercury pharmae process of acquiring Guangzhou Meisuli (美素力) Nutrition Co., Ltd. Established in 2005, Meisuli was registered with a capital of 20 million yuan and registered nine infant formula products in 2017, three stages each for three production lines, “宝素力," &quoiron polymaltose vs ferrous fumaratet;喜素力” and “康素力." If the acquisition is successful, Meisuli will become the fifth infanferrous sulfate liquid iron supplementt formrx iron supplementsula enterprise acquired by Synutra within two years.
Synutra Planned Expansion Spotlighting China’s Dairy Development Strategy
